Page 4 - Trepl News Today

Emerald Advisers LLC cut its stake in Replimune Group, Inc. (NASDAQ:REPL – Free Report) by 18.8% in the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 963,041 shares of the company’s stock after selling 223,000 shares during the period. Emerald Advisers LLC […]

Emerald Mutual Fund Advisers Trust lessened its position in Replimune Group, Inc. (NASDAQ:REPL – Free Report) by 16.8% during the 1st quarter, Holdings Channel reports. The firm owned 803,448 shares of the company’s stock after selling 162,490 shares during the quarter. Emerald Mutual Fund Advisers Trust’s holdings in Replimune Group were worth $14,189,000 at the […]

One of the big things that they want to do is have this theater pay no attention to the pa att the curtain portray p an heir, an aura of strengthora yoght hereof. so while kamala harris doesnt add anything to the ticket, you have to wonder what woul tod gavin newsom add. maybe he would invigorate some of the left wingers, but a lo. tt of the folks that lookt his technocratic california and say, thats the future. i wantwant for for california, r this, for this country might already be on bidens s...

Replimune Group (NASDAQ:REPL – Get Rating) had its price target raised by HC Wainwright from $50.00 to $51.00 in a research report released on Monday, The Fly reports. HC Wainwright also issued estimates for Replimune Group’s Q1 2024 earnings at ($0.80) EPS, Q2 2024 earnings at ($0.84) EPS, Q3 2024 earnings at ($0.88) EPS, Q4 […]

Replimune Group, Inc. (NASDAQ:REPL – Get Rating) – Wedbush cut their FY2024 earnings per share estimates for shares of Replimune Group in a research note issued to investors on Monday, May 22nd. Wedbush analyst R. Driscoll now expects that the company will post earnings of ($3.95) per share for the year, down from their previous […]

…

Replimune Group, Inc. (NASDAQ:REPL – Get Rating) has received an average rating of “Buy” from the six research firms that are currently covering the stock, MarketBeat reports. Six research analysts have rated the stock with a buy recommendation. The average 12 month price objective among brokerages that have issued ratings on the stock in the […]

Replimune Group, Inc. (NASDAQ:REPL – Get Rating) – Investment analysts at Wedbush issued their Q1 2024 earnings estimates for shares of Replimune Group in a research report issued on Monday, May 22nd. Wedbush analyst R. Driscoll anticipates that the company will post earnings of ($0.87) per share for the quarter. The consensus estimate for Replimune […]

Replimune Group, Inc. (NASDAQ:REPL – Get Rating) CFO Jean M. Franchi sold 11,351 shares of the firm’s stock in a transaction on Tuesday, May 16th. The shares were sold at an average price of $18.05, for a total value of $204,885.55. Following the completion of the transaction, the chief financial officer now owns 128,748 shares […]

Replimune Group, Inc. (NASDAQ:REPL – Get Rating) CEO Philip Astley-Sparke sold 17,902 shares of the stock in a transaction dated Tuesday, May 16th. The shares were sold at an average price of $18.05, for a total transaction of $323,131.10. Following the completion of the transaction, the chief executive officer now directly owns 1,525,278 shares of […]